Biotech Association warns legislation would make VT least friendly state for biotech and life sciences
In testimony to the Legislature, New England Biotech Association (NEBA) has warned that a bill under consideration by the Vermont Legislature will create the most restrictive and onerous regulatory environment for biotechnology growth and development in both New England and the nation. The bill, 48/H. 270, would established stricter controls on interactions between the biopharmeceutical industry and health care professionals.